Role of ABC transporters in the pathogenesis of Alzheimers disease

ACS Chemical Neuroscience

Volumn 3, Issue 11, 2012, Pages 820-831

  Abuznait, Alaa H ^a   Kaddoumi, Amal ^a  

^a UNIVERSITY OF LOUISIANA AT MONROE   (United States)

Author keywords

ABC transporters; ABCA1; Alzheimers disease; BCRP; blood brain barrier; MRP1; P glycoprotein

Indexed keywords

3 [3 [[2 CHLORO 3 (TRIFLUOROMETHYL)BENZYL](2 DIPHENYLETHYL)AMINO]PROPOXY]PHENYLACETIC ACID; ABC TRANSPORTER; ABC TRANSPORTER G1; ADVANCED GLYCATION END PRODUCT RECEPTOR; AMYLOID BETA PROTEIN[1-42]; AMYLOID PRECURSOR PROTEIN; APOLIPOPROTEIN E2; APOLIPOPROTEIN E3; APOLIPOPROTEIN E4; BETA SECRETASE; BREAST CANCER RESISTANCE PROTEIN; CAFFEINE; CYCLOSPORIN A; DEXAMETHASONE; DICKKOPF 1 PROTEIN; ELACRIDAR; ESTRADIOL; GAMMA SECRETASE; HYPERFORIN; LOW DENSITY LIPOPROTEIN RECEPTOR; MULTIDRUG RESISTANCE PROTEIN 1; N (2,2,2 TRIFLUOROETHYL) N [4 (2,2,2 TRIFLUORO 1 HYDROXY 1 TRIFLUOROMETHYLETHYL)PHENYL]BENZENESULFONAMIDE; PENTETRAZOLE; PRESENILIN 1; PRESENILIN 2; PROTEIN ABCA2; PROTEIN ABCG4; RIFAMPICIN; TO 90131; UNCLASSIFIED DRUG; VALSPODAR; VERAPAMIL;

ALZHEIMER DISEASE; AMINO TERMINAL SEQUENCE; BLOOD BRAIN BARRIER; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL METABOLISM; DEFENSE MECHANISM; DISEASE COURSE; DRUG TARGETING; ENDOTHELIUM CELL; GENETIC VARIABILITY; HIPPOCAMPUS; HUMAN; LIPID PEROXIDATION; NEUROPATHOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TRANSPORT; REVIEW; RISK FACTOR; SENILE PLAQUE; UPREGULATION; WNT SIGNALING PATHWAY;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ATP-BINDING CASSETTE TRANSPORTERS; BIOLOGICAL TRANSPORT; BLOOD-BRAIN BARRIER; HUMANS; NEOPLASM PROTEINS; P-GLYCOPROTEIN;

EID: 84869748975     PISSN: None     EISSN: 19487193     Source Type: Journal    
DOI: 10.1021/cn300077c     Document Type: Review

References (148)

1. de Souza, L. C., Sarazin, M., Goetz, C., and Dubois, B. (2009) Clinical investigations in primary care Front. Neurol. Neurosci. 24, 1-11
2. Selkoe, D. J. (2001) Alzheimers disease: genes, proteins, and therapy Physiol. Rev. 81, 741-766
3. Mozar, H. N., Bal, D. G., and Howard, J. T. (1987) Perspectives on the etiology of Alzheimers disease JAMA, J. Am. Med. Assoc. 257, 1503-1507
4. Hebert, L. E., Scherr, P. A., Bienias, J. L., Bennett, D. A., and Evans, D. A. (2004) State-specific projections through 2025 of Alzheimer disease prevalence Neurology 62, 1645
5. Massoud, F. and Leger, G. C. (2011) Pharmacological treatment of Alzheimer disease Can. J. Psychiatry 56, 579-588
6. DeLaGarza, V. W. (2003) Pharmacologic treatment of Alzheimers disease: an update Am. Fam. Physician 68, 1365-1372
7. Braak, H. and Braak, E. (1991) Neuropathological stageing of Alzheimer-related changes Acta Neuropathol. 82, 239-259
8. Pimplikar, S. W., Nixon, R. A., Robakis, N. K., Shen, J., and Tsai, L. H. (2010) Amyloid-independent mechanisms in Alzheimers disease pathogenesis J. Neurosci. 30, 14946-14954
9. Wenk, G. L. (2003) Neuropathologic changes in Alzheimers disease J. Clin. Psychiatry 64 (Suppl 9) 7-10
10. Bouras, C., Hof, P. R., Giannakopoulos, P., Michel, J. P., and Morrison, J. H. (1994) Regional distribution of neurofibrillary tangles and senile plaques in the cerebral cortex of elderly patients: a quantitative evaluation of a one-year autopsy population from a geriatric hospital Cereb. Cortex 4, 138-150
11. Goedert, M. (1996) Tau protein and the neurofibrillary pathology of Alzheimers disease Ann. N.Y. Acad. Sci. 777, 121-131
12. Tiraboschi, P., Hansen, L. A., Thal, L. J., and Corey-Bloom, J. (2004) The importance of neuritic plaques and tangles to the development and evolution of AD Neurology 62, 1984-1989
13. Hardy, J. (2006) A hundred years of Alzheimers disease research Neuron 52, 3-13
14. Hardy, J. and Selkoe, D. J. (2002) The amyloid hypothesis of Alzheimers disease: progress and problems on the road to therapeutics Science 297, 353-356
15. Reilly, J. F., Games, D., Rydel, R. E., Freedman, S., Schenk, D., Young, W. G., Morrison, J. H., and Bloom, F. E. (2003) Amyloid deposition in the hippocampus and entorhinal cortex: quantitative analysis of a transgenic mouse model Proc. Natl. Acad. Sci. U.S.A. 100, 4837-4842
16. Rogers, J. and Morrison, J. H. (1985) Quantitative morphology and regional and laminar distributions of senile plaques in Alzheimers disease J. Neurosci. 5, 2801-2808
17. Lesne, S., Koh, M. T., Kotilinek, L., Kayed, R., Glabe, C. G., Yang, A., Gallagher, M., and Ashe, K. H. (2006) A specific amyloid-beta protein assembly in the brain impairs memory Nature 440, 352-357
18. Masters, C. L., Simms, G., Weinman, N. A., Multhaup, G., McDonald, B. L., and Beyreuther, K. (1985) Amyloid plaque core protein in Alzheimer disease and Down syndrome Proc. Natl. Acad. Sci. U.S.A. 82, 4245-4249
19. Shibata, M., Yamada, S., Kumar, S. R., Calero, M., Bading, J., Frangione, B., Holtzman, D. M., Miller, C. A., Strickland, D. K., Ghiso, J., and Zlokovic, B. V. (2000) Clearance of Alzheimers amyloid-beta(1-40) peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier J. Clin. Invest. 106, 1489-1499
20. Sommer, B. (2002) Alzheimers disease and the amyloid cascade hypothesis: ten years on Curr. Opin. Pharmacol. 2, 87-92
21. Kar, S., Slowikowski, S. P., Westaway, D., and Mount, H. T. (2004) Interactions between beta-amyloid and central cholinergic neurons: implications for Alzheimers disease J. Psychiatry Neurosci. 29, 427-441
22. Yankner, B. A. (1996) Mechanisms of neuronal degeneration in Alzheimers disease Neuron 16, 921-932
23. Mawuenyega, K. G., Sigurdson, W., Ovod, V., Munsell, L., Kasten, T., Morris, J. C., Yarasheski, K. E., and Bateman, R. J. (2010) Decreased clearance of CNS beta-amyloid in Alzheimers disease Science 330, 1774
24. Levy-Lahad, E., Wasco, W., Poorkaj, P., Romano, D. M., Oshima, J., Pettingell, W. H., Yu, C. E., Jondro, P. D., Schmidt, S. D., and Wang, K. 1995, Candidate gene for the chromosome 1 familial Alzheimers disease locus Science 269, 973-977
25. Sherrington, R., Rogaev, E. I., Liang, Y., Rogaeva, E. A., Levesque, G., Ikeda, M., Chi, H., Lin, C., Li, G., Holman, K., Tsuda, T., Mar, L., Foncin, J. F., Bruni, A. C., Montesi, M. P., Sorbi, S., Rainero, I., Pinessi, L., Nee, L., Chumakov, I., Pollen, D., Brookes, A., Sanseau, P., Polinsky, R. J., Wasco, W., Da Silva, H. A., Haines, J. L., Perkicak-Vance, M. A., Tanzi, R. E., Roses, A. D., Fraser, P. E., Rommens, J. M., and St George-Hyslop, P. H. (1995) Cloning of a gene bearing missense mutations in early-onset familial Alzheimers disease Nature 375, 754-760
26. Wang, Y. J., Zhou, H. D., and Zhou, X. F. (2006) Clearance of amyloid-beta in Alzheimers disease: progress, problems and perspectives Drug Discovery Today 11, 931-938
27. Holmes, C. (2002) Genotype and phenotype in Alzheimers disease Br. J. Psychiatry 180, 131-134
28. van Assema, D. M., Lubberink, M., Bauer, M., van der Flier, W. M., Schuit, R. C., Windhorst, A. D., Comans, E. F., Hoetjes, N. J., Tolboom, N., Langer, O., Muller, M., Scheltens, P., Lammertsma, A. A., and van Berckel, B. N. (2012) Blood-brain barrier P-glycoprotein function in Alzheimers disease Brain 135, 181-189
29. Weller, R. O., Subash, M., Preston, S. D., Mazanti, I., and Carare, R. O. (2008) Perivascular drainage of amyloid-beta peptides from the brain and its failure in cerebral amyloid angiopathy and Alzheimers disease Brain Pathol. 18, 253-266
30. Thal, D. R. (2009) The pre-capillary segment of the blood-brain barrier and its relation to perivascular drainage in Alzheimers disease and small vessel disease TheScientificWorldJournal 9, 557-563
31. de Boer, A. G., van der Sandt, I. C., and Gaillard, P. J. (2003) The role of drug transporters at the blood-brain barrier Annu. Rev. Pharmacol. Toxicol. 43, 629-656
32. Loscher, W. and Potschka, H. (2005) Blood-brain barrier active efflux transporters: ATP-binding cassette gene family NeuroRx 2, 86-98
33. Weiss, N., Miller, F., Cazaubon, S., and Couraud, P. O. (2009) The blood-brain barrier in brain homeostasis and neurological diseases Biochim. Biophys. Acta 1788, 842-857
34. Bart, J., Groen, H. J., Hendrikse, N. H., van der Graaf, W. T., Vaalburg, W., and de Vries, E. G. (2000) The blood-brain barrier and oncology: new insights into function and modulation Cancer Treat. Rev. 26, 449-462
35. Kwan, P. and Brodie, M. J. (2005) Potential role of drug transporters in the pathogenesis of medically intractable epilepsy Epilepsia 46, 224-235
36. Gottesman, M. M., Fojo, T., and Bates, S. E. (2002) Multidrug resistance in cancer: role of ATP-dependent transporters Nat. Rev. Cancer 2, 48-58
37. Nicolazzo, J. A. and Mehta, D. C. (2010) Transport of drugs across the blood-brain barrier in Alzheimers disease Ther. Delivery 1, 595-611
38. Abuznait, A. H., Cain, C., Ingram, D., Burk, D., and Kaddoumi, A. (2011) Up-regulation of P-glycoprotein reduces intracellular accumulation of beta amyloid: investigation of P-glycoprotein as a novel therapeutic target for Alzheimers disease J. Pharm. Pharmacol. 63, 1111-1118
39. Rapposelli, S., Digiacomo, M., and Balsamo, A. (2009) P-gp transporter and its role in neurodegenerative diseases Curr. Top. Med. Chem. 9, 209-217
40. Bell, R. D. and Zlokovic, B. V. (2009) Neurovascular mechanisms and blood-brain barrier disorder in Alzheimers disease Acta Neuropathol. 118, 103-113
41. Thiebaut, F., Tsuruo, T., Hamada, H., Gottesman, M. M., Pastan, I., and Willingham, M. C. (1987) Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues Proc. Natl. Acad. Sci. U.S.A. 84, 7735-7738
42. Beaulieu, E., Demeule, M., Ghitescu, L., and Beliveau, R. (1997) P-glycoprotein is strongly expressed in the luminal membranes of the endothelium of blood vessels in the brain Biochem. J. 326 (Pt 2) 539-544
43. Miller, D. S., Bauer, B., and Hartz, A. M. (2008) Modulation of P-glycoprotein at the blood-brain barrier: opportunities to improve central nervous system pharmacotherapy Pharmacol. Rev. 60, 196-209
44. Decleves, X., Regina, A., Laplanche, J. L., Roux, F., Boval, B., Launay, J. M., and Scherrmann, J. M. (2000) Functional expression of P-glycoprotein and multidrug resistance-associated protein (Mrp1) in primary cultures of rat astrocytes J. Neurosci. Res. 60, 594-601
45. Ronaldson, P. T., Lee, G., Dallas, S., and Bendayan, R. (2004) Involvement of P-glycoprotein in the transport of saquinavir and indinavir in rat brain microvessel endothelial and microglia cell lines Pharm. Res. 21, 811-818
46. Ronaldson, P. T., Bendayan, M., Gingras, D., Piquette-Miller, M., and Bendayan, R. (2004) Cellular localization and functional expression of P-glycoprotein in rat astrocyte cultures J. Neurochem. 89, 788-800
47. Daood, M., Tsai, C., Ahdab-Barmada, M., and Watchko, J. F. (2008) ABC transporter (P-gp/ABCB1, MRP1/ABCC1, BCRP/ABCG2) expression in the developing human CNS Neuropediatrics 39, 211-218
48. Volk, H., Potschka, H., and Loscher, W. (2005) Immunohistochemical localization of P-glycoprotein in rat brain and detection of its increased expression by seizures are sensitive to fixation and staining variables J. Histochem. Cytochem. 53, 517-531
49. Aronica, E., Gorter, J. A., Jansen, G. H., van Veelen, C. W., van Rijen, P. C., Leenstra, S., Ramkema, M., Scheffer, G. L., Scheper, R. J., and Troost, D. (2003) Expression and cellular distribution of multidrug transporter proteins in two major causes of medically intractable epilepsy: focal cortical dysplasia and glioneuronal tumors Neuroscience 118, 417-429
50. Ak, H., Ay, B., Tanriverdi, T., Sanus, G. Z., Is, M., Sar, M., Oz, B., Ozkara, C., Ozyurt, E., and Uzan, M. (2007) Expression and cellular distribution of multidrug resistance-related proteins in patients with focal cortical dysplasia Seizure 16, 493-503
51. Ramos, A. J., Lazarowski, A., Villar, M. J., and Brusco, A. (2004) Transient expression of MDR-1/P-glycoprotein in a model of partial cortical devascularization Cell. Mol. Neurobiol. 24, 101-107
52. Lam, F. C., Liu, R., Lu, P., Shapiro, A. B., Renoir, J. M., Sharom, F. J., and Reiner, P. B. (2001) beta-Amyloid efflux mediated by p-glycoprotein J. Neurochem. 76, 1121-1128
53. Kuhnke, D., Jedlitschky, G., Grube, M., Krohn, M., Jucker, M., Mosyagin, I., Cascorbi, I., Walker, L. C., Kroemer, H. K., Warzok, R. W., and Vogelgesang, S. (2007) MDR1-P-Glycoprotein (ABCB1) Mediates Transport of Alzheimers amyloid-beta peptides - implications for the mechanisms of Abeta clearance at the blood-brain barrier Brain Pathol. 17, 347-353
54. Cirrito, J. R., Deane, R., Fagan, A. M., Spinner, M. L., Parsadanian, M., Finn, M. B., Jiang, H., Prior, J. L., Sagare, A., Bales, K. R., Paul, S. M., Zlokovic, B. V., Piwnica-Worms, D., and Holtzman, D. M. (2005) P-glycoprotein deficiency at the blood-brain barrier increases amyloid-beta deposition in an Alzheimer disease mouse model J. Clin. Invest. 115, 3285-3290
55. Vogelgesang, S., Cascorbi, I., Schroeder, E., Pahnke, J., Kroemer, H. K., Siegmund, W., Kunert-Keil, C., Walker, L. C., and Warzok, R. W. (2002) Deposition of Alzheimers beta-amyloid is inversely correlated with P-glycoprotein expression in the brains of elderly non-demented humans Pharmacogenetics 12, 535-541
56. Vogelgesang, S., Warzok, R. W., Cascorbi, I., Kunert-Keil, C., Schroeder, E., Kroemer, H. K., Siegmund, W., Walker, L. C., and Pahnke, J. (2004) The role of P-glycoprotein in cerebral amyloid angiopathy; implications for the early pathogenesis of Alzheimers disease Curr. Alzheimer Res. 1, 121-125
57. Silverberg, G. D., Messier, A. A., Miller, M. C., Machan, J. T., Majmudar, S. S., Stopa, E. G., Donahue, J. E., and Johanson, C. E. (2010) Amyloid efflux transporter expression at the blood-brain barrier declines in normal aging J. Neuropathol. Exp. Neurol. 69, 1034-1043
58. Brenn, A., Grube, M., Peters, M., Fischer, A., Jedlitschky, G., Kroemer, H. K., Warzok, R. W., and Vogelgesang, S. (2011) Beta-Amyloid Downregulates MDR1-P-Glycoprotein (Abcb1) Expression at the Blood-Brain Barrier in Mice Int. J. Alzheimer's Dis. 2011, 690121
59. Wijesuriya, H. C., Bullock, J. Y., Faull, R. L., Hladky, S. B., and Barrand, M. A. (2010) ABC efflux transporters in brain vasculature of Alzheimers subjects Brain Res. 1358, 228-238
60. Nazer, B., Hong, S., and Selkoe, D. J. (2008) LRP promotes endocytosis and degradation, but not transcytosis, of the amyloid-beta peptide in a blood-brain barrier in vitro model Neurobiol. Dis. 30, 94-102
61. Ito, S., Ohtsuki, S., and Terasaki, T. (2006) Functional characterization of the brain-to-blood efflux clearance of human amyloid-beta peptide (1-40) across the rat blood-brain barrier Neurosci. Res. 56, 246-252
62. Tai, L. M., Loughlin, A. J., Male, D. K., and Romero, I. A. (2009) P-glycoprotein and breast cancer resistance protein restrict apical-to-basolateral permeability of human brain endothelium to amyloid-beta J. Cereb. Blood Flow Metab. 29, 1079-1083
63. Candela, P., Gosselet, F., Saint-Pol, J., Sevin, E., Boucau, M. C., Boulanger, E., Cecchelli, R., and Fenart, L. (2010) Apical-to-basolateral transport of amyloid-beta peptides through blood-brain barrier cells is mediated by the receptor for advanced glycation end-products and is restricted by P-glycoprotein J. Alzheimer's Dis. 22, 849-859
64. Kruijtzer, C. M., Beijnen, J. H., Rosing, H., ten Bokkel Huinink, W. W., Schot, M., Jewell, R. C., Paul, E. M., and Schellens, J. H. (2002) Increased oral bioavailability of topotecan in combination with the breast cancer resistance protein and P-glycoprotein inhibitor GF120918 J. Clin. Oncol. 20, 2943-2950
65. Qosa, H., Abuznait, A. H., Hill, R. A., and Kaddoumi, A. (2012) Enhanced Brain Amyloid-beta Clearance by Rifampicin and Caffeine as a Possible Protective Mechanism against Alzheimers Disease J. Alzheimers Dis. 30, 1-15
66. Yan, S. D., Chen, X., Fu, J., Chen, M., Zhu, H., Roher, A., Slattery, T., Zhao, L., Nagashima, M., Morser, J., Migheli, A., Nawroth, P., Stern, D., and Schmidt, A. M. (1996) RAGE and amyloid-beta peptide neurotoxicity in Alzheimers disease Nature 382, 685-691
67. Bauer, B., Hartz, A. M., Fricker, G., and Miller, D. S. (2004) Pregnane X receptor up-regulation of P-glycoprotein expression and transport function at the blood-brain barrier Mol. Pharmacol. 66, 413-419
68. Hartz, A. M., Miller, D. S., and Bauer, B. (2010) Restoring blood-brain barrier P-glycoprotein reduces brain amyloid-beta in a mouse model of Alzheimers disease Mol. Pharmacol. 77, 715-723
69. Koldamova, R., Fitz, N. F., and Lefterov, I. (2010) The role of ATP-binding cassette transporter A1 in Alzheimers disease and neurodegeneration Biochim. Biophys. Acta 1801, 824-830
70. Ohtsuki, S., Watanabe, Y., Hori, S., Suzuki, H., Bhongsatiern, J., Fujiyoshi, M., Kamoi, M., Kamiya, N., Takanaga, H., and Terasaki, T. (2004) mRNA expression of the ATP-binding cassette transporter subfamily A (ABCA) in rat and human brain capillary endothelial cells Biol. Pharm. Bull. 27, 1437-1440
71. Akram, A., Schmeidler, J., Katsel, P., Hof, P. R., and Haroutunian, V. (2010) Increased expression of cholesterol transporter ABCA1 is highly correlated with severity of dementia in AD hippocampus Brain Res. 1318, 167-177
72. Akanuma, S., Ohtsuki, S., Doi, Y., Tachikawa, M., Ito, S., Hori, S., Asashima, T., Hashimoto, T., Yamada, K., Ueda, K., Iwatsubo, T., and Terasaki, T. (2008) ATP-binding cassette transporter A1 (ABCA1) deficiency does not attenuate the brain-to-blood efflux transport of human amyloid-beta peptide (1-40) at the blood-brain barrier Neurochem. Int. 52, 956-961
73. Saint-Pol, J., Vandenhaute, E., Boucau, M. C., Candela, P., Dehouck, L., Cecchelli, R., Dehouck, M. P., Fenart, L., and Gosselet, F. (2012) Brain Pericytes ABCA1 Expression Mediates Cholesterol Efflux but not Cellular Amyloid-beta Peptide Accumulation J. Alzheimer's Dis. 30, 489-503
74. Fan, J., Donkin, J., and Wellington, C. (2009) Greasing the wheels of Abeta clearance in Alzheimers disease: the role of lipids and apolipoprotein E Biofactors 35, 239-248
75. Folin, M., Baiguera, S., Guidolin, D., Di Liddo, R., Grandi, C., De Carlo, E., Nussdorfer, G. G., and Parnigotto, P. P. (2006) Apolipoprotein-E modulates the cytotoxic effect of beta-amyloid on rat brain endothelium in an isoform-dependent specific manner Int. J. Mol. Med. 17, 821-826
76. Holtzman, D. M., Herz, J., and Bu, G. (2012) Apolipoprotein e and apolipoprotein e receptors: normal biology and roles in Alzheimer disease Cold Spring Harbor Perspect. Med. 2, a006312
77. Strittmatter, W. J. and Roses, A. D. (1995) Apolipoprotein E and Alzheimer disease Proc. Natl. Acad. Sci. U.S.A. 92, 4725-4727
78. Corder, E. H., Saunders, A. M., Strittmatter, W. J., Schmechel, D. E., Gaskell, P. C., Small, G. W., Roses, A. D., Haines, J. L., and Pericak-Vance, M. A. (1993) Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimers disease in late onset families Science 261, 921-923
79. Deane, R., Sagare, A., Hamm, K., Parisi, M., Lane, S., Finn, M. B., Holtzman, D. M., and Zlokovic, B. V. (2008) apoE isoform-specific disruption of amyloid beta peptide clearance from mouse brain J. Clin. Invest. 118, 4002-4013
80. Castellano, J. M., Kim, J., Stewart, F. R., Jiang, H., DeMattos, R. B., Patterson, B. W., Fagan, A. M., Morris, J. C., Mawuenyega, K. G., Cruchaga, C., Goate, A. M., Bales, K. R., Paul, S. M., Bateman, R. J., and Holtzman, D. M. (2011) Human apoE isoforms differentially regulate brain amyloid-beta peptide clearance Sci. Transl. Med. 3, 89ra57
81. Wahrle, S. E., Jiang, H., Parsadanian, M., Kim, J., Li, A., Knoten, A., Jain, S., Hirsch-Reinshagen, V., Wellington, C. L., Bales, K. R., Paul, S. M., and Holtzman, D. M. (2008) Overexpression of ABCA1 reduces amyloid deposition in the PDAPP mouse model of Alzheimer disease J. Clin. Invest. 118, 671-682
82. Tokuda, T., Calero, M., Matsubara, E., Vidal, R., Kumar, A., Permanne, B., Zlokovic, B., Smith, J. D., Ladu, M. J., Rostagno, A., Frangione, B., and Ghiso, J. (2000) Lipidation of apolipoprotein E influences its isoform-specific interaction with Alzheimers amyloid beta peptides Biochem. J. 348 (Pt 2) 359-365
83. Holtzman, D. M., Bales, K. R., Tenkova, T., Fagan, A. M., Parsadanian, M., Sartorius, L. J., Mackey, B., Olney, J., McKeel, D., Wozniak, D., and Paul, S. M. (2000) Apolipoprotein E isoform-dependent amyloid deposition and neuritic degeneration in a mouse model of Alzheimers disease Proc. Natl. Acad. Sci. U.S.A. 97, 2892-2897
84. Carter, D. B., Dunn, E., McKinley, D. D., Stratman, N. C., Boyle, T. P., Kuiper, S. L., Oostveen, J. A., Weaver, R. J., Boller, J. A., and Gurney, M. E. (2001) Human apolipoprotein E4 accelerates beta-amyloid deposition in APPsw transgenic mouse brain Ann. Neurol. 50, 468-475
85. Chen, X., Guo, Z., Okoro, E. U., Zhang, H., Zhou, L., Lin, X., Rollins, A. T., and Yang, H. (2012) Up-regulation of ATP binding cassette transporter A1 expression by very low density lipoprotein receptor and apolipoprotein E receptor 2 J. Biol. Chem. 287, 3751-3759
86. ElAli, A., Urrutia, A., Rubio-Araiz, A., Hernandez-Jimenez, M., Colado, M. I., Doeppner, T. R., and Hermann, D. M. (2012) Apolipoprotein-E controls adenosine triphosphate-binding cassette transporters ABCB1 and ABCC1 on cerebral microvessels after methamphetamine intoxication Stroke 43, 1647-1653
87. Wahrle, S. E., Jiang, H., Parsadanian, M., Legleiter, J., Han, X., Fryer, J. D., Kowalewski, T., and Holtzman, D. M. (2004) ABCA1 is required for normal central nervous system ApoE levels and for lipidation of astrocyte-secreted apoE J. Biol. Chem. 279, 40987-40993
88. Wahrle, S. E., Jiang, H., Parsadanian, M., Hartman, R. E., Bales, K. R., Paul, S. M., and Holtzman, D. M. (2005) Deletion of Abca1 increases Abeta deposition in the PDAPP transgenic mouse model of Alzheimer disease J. Biol. Chem. 280, 43236-43242
89. Hirsch-Reinshagen, V., Maia, L. F., Burgess, B. L., Blain, J. F., Naus, K. E., McIsaac, S. A., Parkinson, P. F., Chan, J. Y., Tansley, G. H., Hayden, M. R., Poirier, J., Van Nostrand, W., and Wellington, C. L. (2005) The absence of ABCA1 decreases soluble ApoE levels but does not diminish amyloid deposition in two murine models of Alzheimer disease J. Biol. Chem. 280, 43243-43256
90. Koldamova, R., Staufenbiel, M., and Lefterov, I. (2005) Lack of ABCA1 considerably decreases brain ApoE level and increases amyloid deposition in APP23 mice J. Biol. Chem. 280, 43224-43235
91. Koldamova, R. P., Lefterov, I. M., Ikonomovic, M. D., Skoko, J., Lefterov, P. I., Isanski, B. A., DeKosky, S. T., and Lazo, J. S. (2003) 22R-hydroxycholesterol and 9-cis-retinoic acid induce ATP-binding cassette transporter A1 expression and cholesterol efflux in brain cells and decrease amyloid beta secretion J. Biol. Chem. 278, 13244-13256
92. Kim, W. S., Rahmanto, A. S., Kamili, A., Rye, K. A., Guillemin, G. J., Gelissen, I. C., Jessup, W., Hill, A. F., and Garner, B. (2007) Role of ABCG1 and ABCA1 in regulation of neuronal cholesterol efflux to apolipoprotein E discs and suppression of amyloid-beta peptide generation J. Biol. Chem. 282, 2851-2861
93. Jiang, Q., Lee, C. Y., Mandrekar, S., Wilkinson, B., Cramer, P., Zelcer, N., Mann, K., Lamb, B., Willson, T. M., Collins, J. L., Richardson, J. C., Smith, J. D., Comery, T. A., Riddell, D., Holtzman, D. M., Tontonoz, P., and Landreth, G. E. (2008) ApoE promotes the proteolytic degradation of Abeta Neuron 58, 681-693
94. Sun, Y., Yao, J., Kim, T. W., and Tall, A. R. (2003) Expression of liver X receptor target genes decreases cellular amyloid beta peptide secretion J. Biol. Chem. 278, 27688-27694
95. Simons, M., Keller, P., De Strooper, B., Beyreuther, K., Dotti, C. G., and Simons, K. (1998) Cholesterol depletion inhibits the generation of beta-amyloid in hippocampal neurons Proc. Natl. Acad. Sci. U.S.A. 95, 6460-6464
96. Puglielli, L., Tanzi, R. E., and Kovacs, D. M. (2003) Alzheimers disease: the cholesterol connection Nat. Neurosci. 6, 345-351
97. Kojro, E., Gimpl, G., Lammich, S., Marz, W., and Fahrenholz, F. (2001) Low cholesterol stimulates the nonamyloidogenic pathway by its effect on the alpha -secretase ADAM 10 Proc. Natl. Acad. Sci. U.S.A. 98, 5815-5820
98. Hamon, Y., Broccardo, C., Chambenoit, O., Luciani, M. F., Toti, F., Chaslin, S., Freyssinet, J. M., Devaux, P. F., McNeish, J., Marguet, D., and Chimini, G. (2000) ABC1 promotes engulfment of apoptotic cells and transbilayer redistribution of phosphatidylserine Nat. Cell Biol. 2, 399-406
99. Wang, N., Silver, D. L., Costet, P., and Tall, A. R. (2000) Specific binding of ApoA-I, enhanced cholesterol efflux, and altered plasma membrane morphology in cells expressing ABC1 J. Biol. Chem. 275, 33053-33058
100. Wang, L., Schuster, G. U., Hultenby, K., Zhang, Q., Andersson, S., and Gustafsson, J. A. (2002) Liver X receptors in the central nervous system: from lipid homeostasis to neuronal degeneration Proc. Natl. Acad. Sci. U.S.A. 99, 13878-13883
101. Whitney, K. D., Watson, M. A., Collins, J. L., Benson, W. G., Stone, T. M., Numerick, M. J., Tippin, T. K., Wilson, J. G., Winegar, D. A., and Kliewer, S. A. (2002) Regulation of cholesterol homeostasis by the liver X receptors in the central nervous system Mol. Endocrinol. 16, 1378-1385
102. Koldamova, R. P., Lefterov, I. M., Staufenbiel, M., Wolfe, D., Huang, S., Glorioso, J. C., Walter, M., Roth, M. G., and Lazo, J. S. (2005) The liver X receptor ligand T0901317 decreases amyloid beta production in vitro and in a mouse model of Alzheimers disease J. Biol. Chem. 280, 4079-4088
103. Riddell, D. R., Zhou, H., Comery, T. A., Kouranova, E., Lo, C. F., Warwick, H. K., Ring, R. H., Kirksey, Y., Aschmies, S., Xu, J., Kubek, K., Hirst, W. D., Gonzales, C., Chen, Y., Murphy, E., Leonard, S., Vasylyev, D., Oganesian, A., Martone, R. L., Pangalos, M. N., Reinhart, P. H., and Jacobsen, J. S. (2007) The LXR agonist TO901317 selectively lowers hippocampal Abeta42 and improves memory in the Tg2576 mouse model of Alzheimers disease Mol. Cell. Neurosci. 34, 621-628
104. Vanmierlo, T., Rutten, K., Dederen, J., Bloks, V. W., van Vark-van der Zee, L. C., Kuipers, F., Kiliaan, A., Blokland, A., Sijbrands, E. J., Steinbusch, H., Prickaerts, J., Lutjohann, D., and Mulder, M. (2011) Liver X receptor activation restores memory in aged AD mice without reducing amyloid Neurobiol. Aging 32, 1262-1272
105. Terwel, D., Steffensen, K. R., Verghese, P. B., Kummer, M. P., Gustafsson, J. A., Holtzman, D. M., and Heneka, M. T. (2011) Critical role of astroglial apolipoprotein E and liver X receptor-alpha expression for microglial Abeta phagocytosis J. Neurosci. 31, 7049-7059
106. Fukumoto, H., Deng, A., Irizarry, M. C., Fitzgerald, M. L., and Rebeck, G. W. (2002) Induction of the cholesterol transporter ABCA1 in central nervous system cells by liver X receptor agonists increases secreted Abeta levels J. Biol. Chem. 277, 48508-48513
107. Kim, J., Yoon, H., Ramirez, C. M., Lee, S. M., Hoe, H. S., and Fernandez-Hernando, C. (2012) miR-106b impairs cholesterol efflux and increases Abeta levels by repressing ABCA1 expression Exp. Neurol. 235, 476-483
108. Kim, W. S., Bhatia, S., Elliott, D. A., Agholme, L., Kagedal, K., McCann, H., Halliday, G. M., Barnham, K. J., and Garner, B. (2010) Increased ATP-binding cassette transporter A1 expression in Alzheimers disease hippocampal neurons J. Alzheimer's Dis. 21, 193-205
109. Hirsch-Reinshagen, V., Chan, J. Y., Wilkinson, A., Tanaka, T., Fan, J., Ou, G., Maia, L. F., Singaraja, R. R., Hayden, M. R., and Wellington, C. L. (2007) Physiologically regulated transgenic ABCA1 does not reduce amyloid burden or amyloid-beta peptide levels in vivo J. Lipid Res. 48, 914-923
110. Zhao, L. X., Zhou, C. J., Tanaka, A., Nakata, M., Hirabayashi, T., Amachi, T., Shioda, S., Ueda, K., and Inagaki, N. (2000) Cloning, characterization and tissue distribution of the rat ATP-binding cassette (ABC) transporter ABC2/ABCA2 Biochem. J. 350 (Pt 3) 865-872
111. Broccardo, C., Nieoullon, V., Amin, R., Masmejean, F., Carta, S., Tassi, S., Pophillat, M., Rubartelli, A., Pierres, M., Rougon, G., Nieoullon, A., Chazal, G., and Chimini, G. (2006) ABCA2 is a marker of neural progenitors and neuronal subsets in the adult rodent brain J. Neurochem. 97, 345-355
112. Mack, J. T., Townsend, D. M., Beljanski, V., and Tew, K. D. (2007) The ABCA2 transporter: intracellular roles in trafficking and metabolism of LDL-derived cholesterol and sterol-related compounds Curr. Drug Metab. 8, 47-57
113. Chen, Z. J., Vulevic, B., Ile, K. E., Soulika, A., Davis, W., Jr., Reiner, P. B., Connop, B. P., Nathwani, P., Trojanowski, J. Q., and Tew, K. D. (2004) Association of ABCA2 expression with determinants of Alzheimers disease FASEB J. 18, 1129-1131
114. Davis, W., Jr. (2011) The ATP-binding cassette transporter-2 (ABCA2) regulates cholesterol homeostasis and low-density lipoprotein receptor metabolism in N2a neuroblastoma cells Biochim. Biophys. Acta 1811, 1152-1164
115. Davis, W., Jr., Boyd, J. T., Ile, K. E., and Tew, K. D. (2004) Human ATP-binding cassette transporter-2 (ABCA2) positively regulates low-density lipoprotein receptor expression and negatively regulates cholesterol esterification in Chinese hamster ovary cells Biochim. Biophys. Acta 1683, 89-100
116. Grbovic, O. M., Mathews, P. M., Jiang, Y., Schmidt, S. D., Dinakar, R., Summers-Terio, N. B., Ceresa, B. P., Nixon, R. A., and Cataldo, A. M. (2003) Rab5-stimulated up-regulation of the endocytic pathway increases intracellular beta-cleaved amyloid precursor protein carboxyl-terminal fragment levels and Abeta production J. Biol. Chem. 278, 31261-31268
117. Mace, S., Cousin, E., Ricard, S., Genin, E., Spanakis, E., Lafargue-Soubigou, C., Genin, B., Fournel, R., Roche, S., Haussy, G., Massey, F., Soubigou, S., Brefort, G., Benoit, P., Brice, A., Campion, D., Hollis, M., Pradier, L., Benavides, J., and Deleuze, J. F. (2005) ABCA2 is a strong genetic risk factor for early-onset Alzheimers disease Neurobiol. Dis. 18, 119-125
118. Wollmer, M. A., Kapaki, E., Hersberger, M., Muntwyler, J., Brunner, F., Tsolaki, M., Akatsu, H., Kosaka, K., Michikawa, M., Molyva, D., Paraskevas, G. P., Lutjohann, D., von Eckardstein, A., Hock, C., Nitsch, R. M., and Papassotiropoulos, A. (2006) Ethnicity-dependent genetic association of ABCA2 with sporadic Alzheimers disease Am. J. Med. Genet., Part B 141B, 534-536
119. Davis, W., Jr. (2010) The ATP-binding cassette transporter-2 (ABCA2) increases endogenous amyloid precursor protein expression and Abeta fragment generation Curr. Alzheimer Res. 7, 566-577
120. Michaki, V., Guix, F. X., Vennekens, K., Munck, S., Dingwall, C., Davis, J. B., Townsend, D. M., Tew, K. D., Feiguin, F., De Strooper, B., Dotti, C. G., and Wahle, T. (2012) Down-regulation of the ATP-binding cassette transporter 2 (Abca2) reduces amyloid-beta production by altering Nicastrin maturation and intracellular localization J. Biol. Chem. 287, 1100-1111
121. Pike, C. J., Overman, M. J., and Cotman, C. W. (1995) Amino-terminal deletions enhance aggregation of beta-amyloid peptides in vitro J. Biol. Chem. 270, 23895-23898
122. Aronica, E., Gorter, J. A., Redeker, S., van Vliet, E. A., Ramkema, M., Scheffer, G. L., Scheper, R. J., van der Valk, P., Leenstra, S., Baayen, J. C., Spliet, W. G., and Troost, D. (2005) Localization of breast cancer resistance protein (BCRP) in microvessel endothelium of human control and epileptic brain Epilepsia 46, 849-857
123. Maliepaard, M., Scheffer, G. L., Faneyte, I. F., van Gastelen, M. A., Pijnenborg, A. C., Schinkel, A. H., van De Vijver, M. J., Scheper, R. J., and Schellens, J. H. (2001) Subcellular localization and distribution of the breast cancer resistance protein transporter in normal human tissues Cancer Res. 61, 3458-3464
124. Xiong, H., Callaghan, D., Jones, A., Bai, J., Rasquinha, I., Smith, C., Pei, K., Walker, D., Lue, L. F., Stanimirovic, D., and Zhang, W. (2009) ABCG2 is upregulated in Alzheimers brain with cerebral amyloid angiopathy and may act as a gatekeeper at the blood-brain barrier for Abeta(1-40) peptides J. Neurosci. 29, 5463-5475
125. Do, T. M., Noel-Hudson, M. S., Ribes, S., Besengez, C., Smirnova, M., Cisternino, S., Buyse, M., Calon, F., Chimini, G., Chacun, H., Scherrmann, J. M., Farinotti, R., and Bourasset, F. (2012) ABCG2- and ABCG4-mediated efflux of amyloid-beta peptide 1-40 at the mouse blood-brain barrier J. Alzheimer's Dis. 30, 155-166
126. Shen, S., Callaghan, D., Juzwik, C., Xiong, H., Huang, P., and Zhang, W. (2010) ABCG2 reduces ROS-mediated toxicity and inflammation: a potential role in Alzheimers disease J. Neurochem. 114, 1590-1604
127. Schmitz, G., Langmann, T., and Heimerl, S. (2001) Role of ABCG1 and other ABCG family members in lipid metabolism J. Lipid Res. 42, 1513-1520
128. Wang, N., Yvan-Charvet, L., Lutjohann, D., Mulder, M., Vanmierlo, T., Kim, T. W., and Tall, A. R. (2008) ATP-binding cassette transporters G1 and G4 mediate cholesterol and desmosterol efflux to HDL and regulate sterol accumulation in the brain FASEB J. 22, 1073-1082
129. Tarr, P. T. and Edwards, P. A. (2008) ABCG1 and ABCG4 are coexpressed in neurons and astrocytes of the CNS and regulate cholesterol homeostasis through SREBP-2 J. Lipid Res. 49, 169-182
130. Tansley, G. H., Burgess, B. L., Bryan, M. T., Su, Y., Hirsch-Reinshagen, V., Pearce, J., Chan, J. Y., Wilkinson, A., Evans, J., Naus, K. E., McIsaac, S., Bromley, K., Song, W., Yang, H. C., Wang, N., DeMattos, R. B., and Wellington, C. L. (2007) The cholesterol transporter ABCG1 modulates the subcellular distribution and proteolytic processing of beta-amyloid precursor protein J. Lipid Res. 48, 1022-1034
131. Uehara, Y., Yamada, T., Baba, Y., Miura, S., Abe, S., Kitajima, K., Higuchi, M. A., Iwamoto, T., and Saku, K. (2008) ATP-binding cassette transporter G4 is highly expressed in microglia in Alzheimers brain Brain Res. 1217, 239-246
132. Nies, A. T., Jedlitschky, G., Konig, J., Herold-Mende, C., Steiner, H. H., Schmitt, H. P., and Keppler, D. (2004) Expression and immunolocalization of the multidrug resistance proteins, MRP1-MRP6 (ABCC1-ABCC6), in human brain Neuroscience 129, 349-360
133. Soontornmalai, A., Vlaming, M. L., and Fritschy, J. M. (2006) Differential, strain-specific cellular and subcellular distribution of multidrug transporters in murine choroid plexus and blood-brain barrier Neuroscience 138, 159-169
134. van Vliet, E. A., Redeker, S., Aronica, E., Edelbroek, P. M., and Gorter, J. A. (2005) Expression of multidrug transporters MRP1, MRP2, and BCRP shortly after status epilepticus, during the latent period, and in chronic epileptic rats Epilepsia 46, 1569-1580
135. Sugiyama, D., Kusuhara, H., Lee, Y. J., and Sugiyama, Y. (2003) Involvement of multidrug resistance associated protein 1 (Mrp1) in the efflux transport of 17beta estradiol-D-17beta-glucuronide (E217betaG) across the blood-brain barrier Pharm. Res. 20, 1394-1400
136. Rao, V. V., Dahlheimer, J. L., Bardgett, M. E., Snyder, A. Z., Finch, R. A., Sartorelli, A. C., and Piwnica-Worms, D. (1999) Choroid plexus epithelial expression of MDR1 P glycoprotein and multidrug resistance-associated protein contribute to the blood-cerebrospinal-fluid drug-permeability barrier Proc. Natl. Acad. Sci. U.S.A. 96, 3900-3905
137. Bronger, H., Konig, J., Kopplow, K., Steiner, H. H., Ahmadi, R., Herold-Mende, C., Keppler, D., and Nies, A. T. (2005) ABCC drug efflux pumps and organic anion uptake transporters in human gliomas and the blood-tumor barrier Cancer Res. 65, 11419-11428
138. Wijnholds, J., deLange, E. C., Scheffer, G. L., van den Berg, D. J., Mol, C. A., van der Valk, M., Schinkel, A. H., Scheper, R. J., Breimer, D. D., and Borst, P. (2000) Multidrug resistance protein 1 protects the choroid plexus epithelium and contributes to the blood-cerebrospinal fluid barrier J. Clin. Invest. 105, 279-285
139. Sun, H., Johnson, D. R., Finch, R. A., Sartorelli, A. C., Miller, D. W., and Elmquist, W. F. (2001) Transport of fluorescein in MDCKII-MRP1 transfected cells and mrp1-knockout mice Biochem. Biophys. Res. Commun. 284, 863-869
140. Cisternino, S., Rousselle, C., Lorico, A., Rappa, G., and Scherrmann, J. M. (2003) Apparent lack of Mrp1-mediated efflux at the luminal side of mouse blood-brain barrier endothelial cells Pharm. Res. 20, 904-909
141. Sultana, R. and Butterfield, D. A. (2004) Oxidatively modified GST and MRP1 in Alzheimers disease brain: implications for accumulation of reactive lipid peroxidation products Neurochem. Res. 29, 2215-2220
142. Butterfield, D. A., Castegna, A., Lauderback, C. M., and Drake, J. (2002) Evidence that amyloid beta-peptide-induced lipid peroxidation and its sequelae in Alzheimers disease brain contribute to neuronal death Neurobiol. Aging 23, 655-664
143. Markesbery, W. R. and Lovell, M. A. (1998) Four-hydroxynonenal, a product of lipid peroxidation, is increased in the brain in Alzheimers disease Neurobiol. Aging 19, 33-36
144. Lovell, M. A., Xie, C., and Markesbery, W. R. (2000) Acrolein, a product of lipid peroxidation, inhibits glucose and glutamate uptake in primary neuronal cultures Free Radical Biol. Med. 29, 714-720
145. McGrath, L. T., McGleenon, B. M., Brennan, S., McColl, D., Mc, I. S., and Passmore, A. P. (2001) Increased oxidative stress in Alzheimers disease as assessed with 4-hydroxynonenal but not malondialdehyde QJM 94, 485-490
146. Lovell, M. A., Ehmann, W. D., Mattson, M. P., and Markesbery, W. R. (1997) Elevated 4-hydroxynonenal in ventricular fluid in Alzheimers disease Neurobiol. Aging 18, 457-461
147. Lovell, M. A., Xie, C., and Markesbery, W. R. (1998) Decreased glutathione transferase activity in brain and ventricular fluid in Alzheimers disease Neurology 51, 1562-1566
148. Krohn, M., Lange, C., Hofrichter, J., Scheffler, K., Stenzel, J., Steffen, J., Schumacher, T., Bruning, T., Plath, A. S., Alfen, F., Schmidt, A., Winter, F., Rateitschak, K., Wree, A., Gsponer, J., Walker, L. C., and Pahnke, J. (2011) Cerebral amyloid-beta proteostasis is regulated by the membrane transport protein ABCC1 in mice J. Clin. Invest. 121, 3924-3931